Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market – StreetInsider.comBy / June 9, 2020 Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market StreetInsider.com Share this:TweetReddit
